MyFinsight

HomeCompareBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Apnimed, Inc. (APMD)

Apnimed, Inc. (APMD)

||
||

Balance Sheets Overview

Current Ratio
519.34%
Quick Ratio
519.34%
Cash Ratio
485.70%
Debt to Asset Ratio
64.31%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Contingent asset
    • Prepaid assets, other current as...
    • Others
Liabilities Breakdown
    • Convertible preferred stock, 0.0...
    • Accumulated deficit
    • Debt
    • Others
Balance Sheets
2026-06-30
Cash and cash equivalents
172,804
Prepaid research and development
1,407
Accounts receivable
690
Deferred transaction costs
4,779
Prepaid assets, other current assets and other assets
5,092
Total current assets
184,772
Total property and equipment gross
117
Accumulated depreciation
64
Property and equipment, net
53
Assets held for sale
0
Contingent asset
9,893
Operating lease right-of-use asset
714
Other assets
24
Total assets
195,456
Accounts payable
6,598
Accrued expenses and other current liabilities
9,184
Operating lease liability
265
Short-term deferred revenue
19,531
Total current liabilities
35,578
Operating lease liability, net of current
485
Convertible notes
39,331
Debt
40,267
Revenue interest liability
10,037
Deposit liability
0
Deferred revenue
0
Total liabilities
125,698
Convertible preferred stock, 0.00001 par value, 29,557,303 and 25,934,116 shares authorized as of june 30, 2026 and december 31, 2025, respectively 28,522,107 shares issued and outstanding as of june 30, 2026 and december 31, 2025. liquidation preference of 249,518 and 224,518 as of june 30, 2026 and december 31, 2025, respectively
245,939
Common stock, 0.00001 par value, 51,712,954 (48,567,709 class a, 2,948,668 class b, and 196,577 class c) shares authorized as of june 30, 2026 and 45,627,228 (42,481,983 class a, 2,948,668 class b, and 196,577 class c) shares authorized as of december 31, 2025 4,801,823 (1,853,155 class a, 2,752,091 class b, and 196,577 class c) shares issued and outstanding as of june 30, 2026 and 5,420,855 (2,472,187 class a, 2,752,091 class b, and 196,577 class c) shares issued and outstanding as of december 31, 2025
1
Additional paid-in capital
27,508
Accumulated deficit
-203,690
Total stockholders' deficit
-176,181
Total liabilities, convertible preferred stock and stockholders' deficit
195,456
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$172,804K Prepaid assets, othercurrent assets and other...$5,092K Deferred transactioncosts$4,779K Prepaid research anddevelopment$1,407K Accounts receivable$690K Total property andequipment gross$117K Total current assets$184,772K Contingent asset$9,893K Operating leaseright-of-use asset$714K Property and equipment,net$53K Other assets$24K Accumulated depreciation$64K Total assets$195,456K Accumulated deficit-$203,690K Total liabilities,convertible preferred stock...$195,456K Total stockholders'deficit-$176,181K Additional paid-in capital$27,508K Common stock, 0.00001par value,...$1K Convertible preferredstock, 0.00001 par...$245,939K Total liabilities$125,698K Debt$40,267K Convertible notes$39,331K Total currentliabilities$35,578K Revenue interestliability$10,037K Operating leaseliability, net of current$485K Short-term deferredrevenue$19,531K Accrued expenses andother current...$9,184K Accounts payable$6,598K Operating lease liability$265K